<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="case-report">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">BMC Neurol</journal-id>
      <journal-id journal-id-type="iso-abbrev">BMC Neurol</journal-id>
      <journal-title-group>
        <journal-title>BMC Neurology</journal-title>
      </journal-title-group>
      <issn pub-type="epub">1471-2377</issn>
      <publisher>
        <publisher-name>BioMed Central</publisher-name>
        <publisher-loc>London</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">27416922</article-id>
      <article-id pub-id-type="pmc">4946170</article-id>
      <article-id pub-id-type="publisher-id">632</article-id>
      <article-id pub-id-type="doi">10.1186/s12883-016-0632-1</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Case Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Anomalous vascularization in a Wnt medulloblastoma: a case report</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author" corresp="yes">
          <name>
            <surname>Di Giannatale</surname>
            <given-names>Angela</given-names>
          </name>
          <address>
            <phone>(+39) 06 68593697</phone>
            <email>angela.digiannatale@opbg.net</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Carai</surname>
            <given-names>Andrea</given-names>
          </name>
          <address>
            <email>andrea.carai@opbg.net</email>
          </address>
          <xref ref-type="aff" rid="Aff2"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Cacchione</surname>
            <given-names>Antonella</given-names>
          </name>
          <address>
            <email>antonella.cacchione@opbg.net</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Marrazzo</surname>
            <given-names>Antonio</given-names>
          </name>
          <address>
            <email>ant.marrazzo@hotmail.it</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Dell&#x2019;Anna</surname>
            <given-names>Vito Andrea</given-names>
          </name>
          <address>
            <email>vitoandrea.dellanna@gmail.com</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Colafati</surname>
            <given-names>Giovanna Stefania</given-names>
          </name>
          <address>
            <email>gstefania.colafati@opbg.net</email>
          </address>
          <xref ref-type="aff" rid="Aff3"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Diomedi-Camassei</surname>
            <given-names>Francesca</given-names>
          </name>
          <address>
            <email>francesca.diomedi@opbg.net</email>
          </address>
          <xref ref-type="aff" rid="Aff4"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Miele</surname>
            <given-names>Evelina</given-names>
          </name>
          <address>
            <email>evelina.Miele@uniroma1.it</email>
          </address>
          <xref ref-type="aff" rid="Aff5"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Po</surname>
            <given-names>Agnese</given-names>
          </name>
          <address>
            <email>agnese.Po@uniroma1.it</email>
          </address>
          <xref ref-type="aff" rid="Aff6"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Ferretti</surname>
            <given-names>Elisabetta</given-names>
          </name>
          <address>
            <email>elisabetta.ferretti@uniroma1.it</email>
          </address>
          <xref ref-type="aff" rid="Aff6"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Locatelli</surname>
            <given-names>Franco</given-names>
          </name>
          <address>
            <email>franco.locatelli@opbg.net</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
          <xref ref-type="aff" rid="Aff7"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Mastronuzzi</surname>
            <given-names>Angela</given-names>
          </name>
          <address>
            <email>angela.mastronuzzi@opbg.net</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <aff id="Aff1"><label/>Department of Hematology/Oncology and Stem Cell Transplantation, Bambino Ges&#xF9; Children&#x2019;s Hospital, IRCCS, Piazza di Sant&#x2019;Onofrio, 4 &#x2013; 00165 Rome, Italy </aff>
        <aff id="Aff2"><label/>Department of Neuroscience and Neurorehabilitation, Neurosurgery Unit, Bambino Ges&#xF9; Children&#x2019;s Hospital, IRCCS, Piazza di Sant&#x2019;Onofrio, 4 &#x2013; 00165 Rome, Italy </aff>
        <aff id="Aff3"><label/>Imaging Department, Neuroradiology Unit, Bambino Ges&#xF9; Children&#x2019;s Hospital, IRCCS, Piazza di Sant&#x2019;Onofrio, 4 &#x2013; 00165 Rome, Italy </aff>
        <aff id="Aff4"><label/>Department of Laboratories - Pathology Unit, Bambino Ges&#xF9; Children&#x2019;s Hospital, IRCCS, Piazza di Sant&#x2019;Onofrio, 4 &#x2013; 00165 Rome, Italy </aff>
        <aff id="Aff5"><label/>Center for Life NanoScience@Sapienza, Istituto Italiano di Tecnologia, Viale Regina Elena 291, 00161 Rome, Italy </aff>
        <aff id="Aff6"><label/>Department of Molecular Medicine, Sapienza University, Viale Regina Elena 291, 00161 Rome, Italy </aff>
        <aff id="Aff7"><label/>Department of Pediatric Science, University of Pavia, Viale Brambilla 74, 27100 Pavia, Italy </aff>
      </contrib-group>
      <pub-date pub-type="epub">
        <day>15</day>
        <month>7</month>
        <year>2016</year>
      </pub-date>
      <pub-date pub-type="pmc-release">
        <day>15</day>
        <month>7</month>
        <year>2016</year>
      </pub-date>
      <pub-date pub-type="collection">
        <year>2016</year>
      </pub-date>
      <volume>16</volume>
      <elocation-id>103</elocation-id>
      <history>
        <date date-type="received">
          <day>23</day>
          <month>3</month>
          <year>2016</year>
        </date>
        <date date-type="accepted">
          <day>6</day>
          <month>7</month>
          <year>2016</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; The Author(s). 2016</copyright-statement>
        <license license-type="OpenAccess">
          <license-p>
<bold>Open Access</bold>This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p>
        </license>
      </permissions>
      <abstract id="Abs1">
        <sec>
          <title>Background</title>
          <p>Medulloblastoma is the most common malignant brain tumor in children. To date only few cases of medulloblastoma with hemorrhages have been reported in the literature. Although some studies speculate on the pathogenesis of this anomalous increased vascularization in medulloblastoma, the specific mechanism is still far from clearly understood. A correlation between molecular medulloblastoma subgroups and hemorrhagic features has not been reported, although recent preliminary studies described that WNT-subtype tumors display increased vascularization and hemorrhaging.</p>
        </sec>
        <sec>
          <title>Case presentation</title>
          <p>Herein, we describe a child with a Wnt-medulloblastoma presenting as cerebellar-vermian hemorrhagic lesion. Brain magnetic resonance imaging (MRI) showed the presence of a midline posterior fossa mass with a cystic hemorrhagic component. The differential diagnosis based on imaging included cavernous hemangioma, arteriovenous malformation and traumatic lesion. At surgery, the tumor appeared richly vascularized as documented by the preoperative angiography.</p>
        </sec>
        <sec>
          <title>Conclusions</title>
          <p>The case we present showed that Wnt medulloblastoma may be associated with anomalous vascularization. Further studies are needed to elucidate if there is a link between the hypervascularization and the Wnt/&#x3B2;-catenin signaling activation and if this abnormal vasculature might influence drug penetration contributing to good prognosis of this medulloblastoma subgroup.</p>
        </sec>
      </abstract>
      <kwd-group xml:lang="en">
        <title>Keywords</title>
        <kwd>Case report</kwd>
        <kwd>Medulloblastoma</kwd>
        <kwd>Wnt/&#x3B2;-catenin</kwd>
        <kwd>Angiogenesis</kwd>
      </kwd-group>
      <custom-meta-group>
        <custom-meta>
          <meta-name>issue-copyright-statement</meta-name>
          <meta-value>&#xA9; The Author(s) 2016</meta-value>
        </custom-meta>
      </custom-meta-group>
    </article-meta>
  </front>
  <body>
    <sec id="Sec1">
      <title>Background</title>
      <p>Medulloblastoma is the most common malignant brain tumor in children, representing approximately 25&#xA0;% of all pediatric brain tumors [<xref ref-type="bibr" rid="CR1">1</xref>]. Current molecular stratification consists in four subgroups associated with different pathways defined as Wnt, Sonic Hedgehog Homolog (SHH), group 3, and group 4 [<xref ref-type="bibr" rid="CR2">2</xref>]. Wnt subtype is the rarest subgroup, accounting for 10&#xA0;% of medulloblastomas [<xref ref-type="bibr" rid="CR3">3</xref>] and patients with this pathway activation have a very good long-term prognosis [<xref ref-type="bibr" rid="CR4">4</xref>]. However, the biological effect of Wnt/&#x3B2;-catenin signaling activation and the link with a better prognosis has not been clarified yet. Few cases of medulloblastoma presenting with spontaneous hemorrhage are reported in the literature [<xref ref-type="bibr" rid="CR5">5</xref>]. Although some studies speculate on the etiology of the anomalous increased vascularization in medulloblastoma [<xref ref-type="bibr" rid="CR6">6</xref>], a clear pathogenetic role has not been identified. A correlation between specific medulloblastoma subgroup and hemorrhagic features has not been reported [<xref ref-type="bibr" rid="CR7">7</xref>], however a recent paper demonstrated that Wnt medulloblastoma secretes Wnt antagonists that increase the permeability of the blood&#x2013;brain barrier (BBB) [<xref ref-type="bibr" rid="CR8">8</xref>]. Furthermore, a personal communication hypothesized that this aberrant vascular network may be associate with the Wnt subgroup [<xref ref-type="bibr" rid="CR9">9</xref>]. Herein, we report the case of a child with a Wnt medulloblastoma presenting as a hemorrhagic cerebellar-vermian lesion.</p>
    </sec>
    <sec id="Sec2">
      <title>Case presentation</title>
      <p>A 7-year-old girl presented to the emergency department of Bambino Ges&#xF9; Children&#x2019;s Hospital with a one-month history of headache and vomiting. Neurological examination was normal apart from mild dysmetria at the upper extremities. Multidetector computed tomography (MDCT) reconstruction images show a hyperdense cerebellar-vermian lesion, with fluid-blood levels. This finding was confirmed by brain magnetic resonance imaging (MRI) that showed the presence of a mass with a hyperintense cystic hemorrhagic component, heterogeneous enhancement, poor perilesional edema and absence of obstructive hydrocephalus (Fig.&#xA0;<xref rid="Fig1" ref-type="fig">1A</xref>). Spinal MRI and cerebrospinal fluid study were normal. Due to these atypical features a cerebral angiography was performed, showing an intratumoral aneurysm-like formation supplied by a vermian branch of the left posterior inferior cerebellar artery (Fig.&#xA0;<xref rid="Fig1" ref-type="fig">1A</xref>). She underwent a midline suboccipital craniotomy with complete resection of the vermian tumor. At surgery, the tumor appeared richly vascularized from vermian branches as documented by the preoperative angiography. Histology (Fig.&#xA0;<xref rid="Fig1" ref-type="fig">1B</xref>) showed a diffuse and multinodular proliferation of small undifferentiated cells and immunohistochemistry revealed positivity for synaptophysin and &#x3B2;-catenin (both cytoplasmic and nuclear), all features consistent with the diagnosis of classic medulloblastoma. The tumor was characterized by anomalous vascularization and harbored some clusters of anomalous, thick-walled vascular structures along with numerous variably anastomosing small venous and capillary structures. Gene expression profile of the tumor confirmed a Wnt molecular subgroup (Fig.&#xA0;<xref rid="Fig2" ref-type="fig">2</xref>). C-Myc amplification was negative (C-Myc/SPAST and C-Myc/PI4KA). She started therapy as per standard arm of European HIT-SIOP PNET 4 trial which is used for the treatment of standard risk medulloblastoma. According to this protocol, she received radiotherapy (23&#xA0;Gy to the craniospinal axis and a total of 54&#xA0;Gy to posterior fossa) given concurrently with weekly vincristine (1.5&#xA0;mg/m<sup>2</sup> i.v.). This treatment was followed by 8&#xA0;cycles of maintenance-chemotherapy consisting of cisplatin (70&#xA0;mg/m<sup>2</sup> i.v.) and lomustine (75&#xA0;mg/ m<sup>2</sup> orally) on day 1 associated to vincristine (1.5&#xA0;mg/m<sup>2</sup> i.v.) on day 1, 8 and 15. At 22&#xA0;months after diagnosis she was doing well with no evidence of disease.<fig id="Fig1"><label>Fig. 1</label><caption><p>MRI and histological findings in the hemorrhagic lesion. (<bold>A</bold>) [CT and MRI findings in the hemorrhagic cerebellar lesion]. Sagittal (a) and Axial (b) MDCT reconstruction images show a hyperdense cerebellar-vermian lesion, with fluid-blood levels (white arrows), confirmed by MRI scan. Axial T2-weighted MRI (c) showed a hemorrhagic cerebellar-vermian lesion, expanding into IV ventricle, with multiple fluid-blood levels (white arrow). Axial-Sagittal T1-weighted MRI, without (d, e) and with (f, g) gadolinium, revealed a solid component inhomogeneously contrast-enhanced (white arrows). Axial gradient-echo sequence (h) showed lack of hypointense hemosiderin rim (cavernous hemangioma classical finding, white arrow). Preoperative left vertebral angiograms (i, l) show hypoplastic vertebral artery terminating as posterior inferior cerebellar artery (vascular variation) and the tumor stain; an aneurysm-like formation (arrow) is seen in the arterial phase. The tumor is fed by the vermian branch of the left posterior inferior cerebellar artery. (<bold>B</bold>) [Histological findings in hemorrhagic medulloblastoma]. Proliferation of small undifferentiated cells showing a diffuse/multinodular pattern (middle-right), associated to anomalous, thick-walled vascular structures (arrows) (a, H&amp;E, 2.5x). Cells were synaptophysin (b, 20x) and beta-catenin (both cytoplasm and nucleus) positive (c, 20x). Anomalous vascularization was characterized by clusters of anomalous, thick-walled arterial-type vessels (d and f, CD31 20x) along with numerous variably anastomosing small venous and capillary structures (e, CD31, 20x)</p></caption><graphic xlink:href="12883_2016_632_Fig1_HTML" id="MO1"/></fig><fig id="Fig2"><label>Fig. 2</label><caption><p>Molecular characterization of medulloblastoma. mRNA levels of the indicated genes in medulloblastoma are compared to normal cerebellum as control (CTRLs). Genes are grouped into four molecular subgroups (WNT, SHH, GROUP 3, GROUP 4) as indicated by the four different colors. Relative quantification values are expressed as linear scale arbitrary units</p></caption><graphic xlink:href="12883_2016_632_Fig2_HTML" id="MO2"/></fig></p>
      <p>The consensus held in Boston in 2010 supported the existence of four main medulloblastoma subgroups based on the molecular profiling and provided important insights not only in the selection of patients for molecular targeted therapies but also in the outcome prediction [<xref ref-type="bibr" rid="CR2">2</xref>, <xref ref-type="bibr" rid="CR3">3</xref>, <xref ref-type="bibr" rid="CR10">10</xref>]. Medulloblastomas with activation of Wnt/&#x3B2;-catenin pathway are rarely metastatic and appear to be a less aggressive variant associated with an excellent prognosis [<xref ref-type="bibr" rid="CR11">11</xref>]. However, the significance of Wnt activation in medulloblastoma remains to be determined. Several findings suggest that wild type &#x3B2;-catenin has an important physiological role in CNS angiogenesis. During embryogenesis, the Wnt pathway has direct actions on axonal growth through interaction with &#x3B2;-catenin complex [<xref ref-type="bibr" rid="CR12">12</xref>]. Moreover, it has been demonstrated that Wnt signaling plays an active role in the induction and maintenance of BBB characteristics during embryonic and postnatal development particularly by regulating tight junction proteins expression [<xref ref-type="bibr" rid="CR13">13</xref>]. Indeed, Wnt/&#x3B2;-catenin signaling is very important for central nervous system (CNS) angiogenesis and conditionally inactivation of &#x3B2;-catenin in the endothelium has been described to alter the development of head vasculature resulting in early embryonic lethality of mice [<xref ref-type="bibr" rid="CR14">14</xref>, <xref ref-type="bibr" rid="CR15">15</xref>]. &#x3B2;-catenin&#x2013;null animals show vessel fragility, in association to a decrease in intercellular adhesion strength and an increase in paracellular permeability leading to vascular leakage and frequent hemorrhages. The critical role of canonical Wnt signaling in endothelial cells for formation and differentiation of the CNS vasculature has been described also in genetic mouse models [<xref ref-type="bibr" rid="CR16">16</xref>]. Recently has been reported that G-protein coupled receptor 124 (GPR124) functions as a specific co-stimulator of &#x3B2;-catenin signaling in brain endothelium and its disruption led to defective CNS angiogenesis and blood brain barriergenesis in mice [<xref ref-type="bibr" rid="CR17">17</xref>]. In mouse embryos, eliminating neuroepithelial Wnt7a and Wnt7b, or endothelial Gpr124 or &#x3B2;-catenin, leads to a reduced CNS angiogenesis with formation of abnormal vascular structures [<xref ref-type="bibr" rid="CR13">13</xref>, <xref ref-type="bibr" rid="CR16">16</xref>, <xref ref-type="bibr" rid="CR18">18</xref>] and has been demonstrated that the interaction of Gpr124 with Reck strongly synergize to promote Wnt/&#x3B2;-catenin signaling during brain angiogenesis [<xref ref-type="bibr" rid="CR19">19</xref>].</p>
      <p>Nevertheless, most of the studies correlating Wnt signaling with CNS vasculature anomalies are developmental phenotypes, and the relevance to post-natal development is not clear. Moreover, &#x3B2;-catenin is important in the regulation of vascular endothelial cell-cell adhesions and barrier function by linking the VE-cadherin junction complex to the cytoskeleton and thus vascular anomalies may arise for a non-signaling role [<xref ref-type="bibr" rid="CR20">20</xref>].</p>
      <p>A recent study showed that genetically modified mouse models harboring Wnt-medulloblastoma had more hemorrhagic tumors compared to SHH or group 3 tumors [<xref ref-type="bibr" rid="CR8">8</xref>]. The authors demonstrated that these effects occur postnatally and reveal that Wnt medulloblastoma secretes Wnt antagonists increasing the permeability of the BBB [<xref ref-type="bibr" rid="CR8">8</xref>].</p>
      <p>We report a girl with a Wnt medulloblastoma presenting an anomalous vascularization. Differential diagnosis based on MRI imaging appearance includes cavernous hemangioma, arteriovenous malformation and traumatic lesion. Angiographic opacification of dilated arteriolar vessels with slow flow and lack of early venous drainage confirmed an aberrant tumor vascular network. This patient is doing well at 22&#xA0;months after diagnosis. Medulloblastoma can present heterogeneous features on MRI with variable enhancement patterns, cystic areas, hemorrhage and calcification [<xref ref-type="bibr" rid="CR21">21</xref>]. Although intratumoral bleeding can be found in brain tumors, only few cases of medulloblastoma with spontaneous hemorrhages have been reported in the literature [<xref ref-type="bibr" rid="CR5">5</xref>, <xref ref-type="bibr" rid="CR22">22</xref>]. Park et al. showed that the incidence of spontaneous hemorrhage was 5.6&#xA0;% in patients with primary or recurrent medulloblastoma [<xref ref-type="bibr" rid="CR23">23</xref>]. A study evaluating vascular regulatory expression profiles across medulloblastoma subgroups documented an upregulation of proangiogenic factors in SHH subgroup [<xref ref-type="bibr" rid="CR6">6</xref>]. Despite specific mechanisms driving aberrant vascularization and hemorrhage in medulloblastoma remain not completely elucidated, new researches revealed that medulloblastoma genotype dictates tumor vessels phenotype [<xref ref-type="bibr" rid="CR8">8</xref>].</p>
    </sec>
    <sec id="Sec3">
      <title>Conclusions</title>
      <p>We reported a case of Wnt/&#x3B2;-catenin medulloblastoma associated with an anomalous vascularization. This may support the evidence that Wnt medulloblastomas may be associated to aberrant vascular network contributing to a better drug penetration and therefore to their excellent prognosis [<xref ref-type="bibr" rid="CR8">8</xref>]. This finding should be further investigated in a large patient cohort in order to elucidate the vascular microenvironment in Wnt medulloblastoma subgroup.</p>
    </sec>
    <sec id="Sec4">
      <title>Abbreviations</title>
      <p>SHH, sonic hedgehog homolog; MDTC, multidetector computed tomography; MRI, magnetic resonance imaging; BBB, blood&#x2013;brain barrier; CNS, central nervous system</p>
    </sec>
  </body>
  <back>
    <ack>
      <title>Acknowledgements</title>
      <p>We thank the child&#x2019;s parents, who gave their informed consent for publication.</p>
      <sec id="FPar1">
        <title>Funding</title>
        <p>No funding to declare.</p>
      </sec>
      <sec id="FPar2">
        <title>Availability of data and materials</title>
        <p>The data supporting our findings will not be shared since is not ethically appropriate (underlying data pose privacy concerns and might reveal the identity of participant).</p>
      </sec>
      <sec id="FPar3">
        <title>Authors&#x2019; contributions</title>
        <p>AM, AC and FL designed the case report; AC, AM, VAD, GSC, FDC, EM, AM and ADG. analyzed data; and AP, EF, ADG wrote the paper. All authors read and approved the final manuscript.</p>
      </sec>
      <sec id="FPar4">
        <title>Competing interests</title>
        <p>The authors declare that they have no competing interests.</p>
      </sec>
      <sec id="FPar5">
        <title>Consent for publication</title>
        <p>Written informed consent for publication of this Case Report and any accompanying images was obtained from patient&#x2019;s parents. A copy of the written consent is available for review to the Editor of this journal.</p>
      </sec>
      <sec id="FPar6">
        <title>Ethics approval and consent to participate</title>
        <p>This clinical study was approved by the local ethical committee of Bambino Ges&#xF9; Children&#x2019;s Hospital.</p>
      </sec>
    </ack>
    <ref-list id="Bib1">
      <title>References</title>
      <ref id="CR1">
        <label>1.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Farwell</surname>
              <given-names>JR</given-names>
            </name>
            <name>
              <surname>Dohrmann</surname>
              <given-names>GJ</given-names>
            </name>
            <name>
              <surname>Flannery</surname>
              <given-names>JT</given-names>
            </name>
          </person-group>
          <article-title>Central nervous system tumors in children</article-title>
          <source>Cancer</source>
          <year>1977</year>
          <volume>40</volume>
          <fpage>3123</fpage>
          <lpage>32</lpage>
          <pub-id pub-id-type="doi">10.1002/1097-0142(197712)40:6&lt;3123::AID-CNCR2820400656&gt;3.0.CO;2-6</pub-id>
          <pub-id pub-id-type="pmid">201364</pub-id>
        </element-citation>
      </ref>
      <ref id="CR2">
        <label>2.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Northcott</surname>
              <given-names>PA</given-names>
            </name>
            <name>
              <surname>Korshunov</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Witt</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Hielscher</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Eberhart</surname>
              <given-names>CG</given-names>
            </name>
            <name>
              <surname>Mack</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Bouffet</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Clifford</surname>
              <given-names>SC</given-names>
            </name>
            <name>
              <surname>Hawkins</surname>
              <given-names>CE</given-names>
            </name>
            <name>
              <surname>French</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Rutka</surname>
              <given-names>JT</given-names>
            </name>
            <name>
              <surname>Pfister</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Taylor</surname>
              <given-names>MD</given-names>
            </name>
          </person-group>
          <article-title>Medulloblastoma comprises four distinct molecular variants</article-title>
          <source>J Clin Oncol</source>
          <year>2011</year>
          <volume>29</volume>
          <fpage>1408</fpage>
          <lpage>1414</lpage>
          <pub-id pub-id-type="doi">10.1200/JCO.2009.27.4324</pub-id>
          <pub-id pub-id-type="pmid">20823417</pub-id>
        </element-citation>
      </ref>
      <ref id="CR3">
        <label>3.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kool</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Korshunov</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Remke</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Jones</surname>
              <given-names>DT</given-names>
            </name>
            <name>
              <surname>Schlanstein</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Northcott</surname>
              <given-names>PA</given-names>
            </name>
            <name>
              <surname>Cho</surname>
              <given-names>YJ</given-names>
            </name>
            <name>
              <surname>Koster</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Schouten-van Meeteren</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>van Vuurden</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Clifford</surname>
              <given-names>SC</given-names>
            </name>
            <name>
              <surname>Pietsch</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>von Bueren</surname>
              <given-names>AO</given-names>
            </name>
            <name>
              <surname>Rutkowski</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>McCabe</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Collins</surname>
              <given-names>VP</given-names>
            </name>
            <name>
              <surname>B&#xE4;cklund</surname>
              <given-names>ML</given-names>
            </name>
            <name>
              <surname>Haberler</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Bourdeaut</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Delattre</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Doz</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Ellison</surname>
              <given-names>DW</given-names>
            </name>
            <name>
              <surname>Gilbertson</surname>
              <given-names>RJ</given-names>
            </name>
            <name>
              <surname>Pomeroy</surname>
              <given-names>SL</given-names>
            </name>
            <name>
              <surname>Taylor</surname>
              <given-names>MD</given-names>
            </name>
            <name>
              <surname>Lichter</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Pfister</surname>
              <given-names>SM</given-names>
            </name>
          </person-group>
          <article-title>Molecular subgroups of medulloblastoma: an international meta-analysis of transcriptome, genetic aberrations, and clinical data of, WNT, SHH, Group 3, and Group 4 medulloblastomas</article-title>
          <source>Acta Neuropathol</source>
          <year>2012</year>
          <volume>123</volume>
          <fpage>473</fpage>
          <lpage>84</lpage>
          <pub-id pub-id-type="doi">10.1007/s00401-012-0958-8</pub-id>
          <pub-id pub-id-type="pmid">22358457</pub-id>
        </element-citation>
      </ref>
      <ref id="CR4">
        <label>4.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ellison</surname>
              <given-names>DW</given-names>
            </name>
            <name>
              <surname>Dalton</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Kocak</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Nicholson</surname>
              <given-names>SL</given-names>
            </name>
            <name>
              <surname>Fraga</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Neale</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Kenney</surname>
              <given-names>AM</given-names>
            </name>
            <name>
              <surname>Brat</surname>
              <given-names>DJ</given-names>
            </name>
            <name>
              <surname>Perry</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Yong</surname>
              <given-names>WH</given-names>
            </name>
            <name>
              <surname>Taylor</surname>
              <given-names>RE</given-names>
            </name>
            <name>
              <surname>Bailey</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Clifford</surname>
              <given-names>SC</given-names>
            </name>
            <name>
              <surname>Gilbertson</surname>
              <given-names>RJ</given-names>
            </name>
          </person-group>
          <article-title>Medulloblastoma: clinicopathological correlates of SHH, WNT, and non-SHH/WNT molecular subgroups</article-title>
          <source>Acta Neuropathol</source>
          <year>2011</year>
          <volume>121</volume>
          <fpage>381</fpage>
          <lpage>96</lpage>
          <pub-id pub-id-type="doi">10.1007/s00401-011-0800-8</pub-id>
          <pub-id pub-id-type="pmid">21267586</pub-id>
        </element-citation>
      </ref>
      <ref id="CR5">
        <label>5.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Menekse</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Gezercan</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Demirturk</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Uysal</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Okten</surname>
              <given-names>AI</given-names>
            </name>
          </person-group>
          <article-title>Fatal cerebellar hemorrhage as an initial presentation of medulloblastoma in a child</article-title>
          <source>J Pediatr Neurosci</source>
          <year>2015</year>
          <volume>10</volume>
          <fpage>287</fpage>
          <lpage>9</lpage>
          <pub-id pub-id-type="doi">10.4103/1817-1745.165727</pub-id>
          <pub-id pub-id-type="pmid">26557180</pub-id>
        </element-citation>
      </ref>
      <ref id="CR6">
        <label>6.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>D&#x2019;Asti</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Kool</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Pfister</surname>
              <given-names>SM</given-names>
            </name>
            <name>
              <surname>Rak</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Coagulation and angiogenic gene expression profiles are defined by molecular subgroups of medulloblastoma: evidence for growth factor-thrombin cross-talk</article-title>
          <source>J Thromb Haemost</source>
          <year>2014</year>
          <volume>12</volume>
          <fpage>1838</fpage>
          <lpage>49</lpage>
          <pub-id pub-id-type="doi">10.1111/jth.12715</pub-id>
          <pub-id pub-id-type="pmid">25163932</pub-id>
        </element-citation>
      </ref>
      <ref id="CR7">
        <label>7.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Perreault</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Ramaswamy</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Achrol</surname>
              <given-names>AS</given-names>
            </name>
            <name>
              <surname>Chao</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Liu</surname>
              <given-names>TT</given-names>
            </name>
            <name>
              <surname>Shih</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Remke</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Schubert</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Bouffet</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Fisher</surname>
              <given-names>PG</given-names>
            </name>
            <name>
              <surname>Partap</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Vogel</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Taylor</surname>
              <given-names>MD</given-names>
            </name>
            <name>
              <surname>Cho</surname>
              <given-names>YJ</given-names>
            </name>
            <name>
              <surname>Yeom</surname>
              <given-names>KW</given-names>
            </name>
          </person-group>
          <article-title>MRI surrogates for molecular subgroups of medulloblastoma</article-title>
          <source>AJNR Am J Neuroradiol</source>
          <year>2014</year>
          <volume>35</volume>
          <fpage>1263</fpage>
          <lpage>9</lpage>
          <pub-id pub-id-type="doi">10.3174/ajnr.A3990</pub-id>
          <pub-id pub-id-type="pmid">24831600</pub-id>
        </element-citation>
      </ref>
      <ref id="CR8">
        <label>8.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Phoenix</surname>
              <given-names>TN</given-names>
            </name>
            <name>
              <surname>Patmore</surname>
              <given-names>DM</given-names>
            </name>
            <name>
              <surname>Boop</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Boulos</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Jacus</surname>
              <given-names>MO</given-names>
            </name>
            <name>
              <surname>Patel</surname>
              <given-names>YT</given-names>
            </name>
            <name>
              <surname>Roussel</surname>
              <given-names>MF</given-names>
            </name>
            <name>
              <surname>Finkelstein</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Goumnerova</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Perreault</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Wadhwa</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Cho</surname>
              <given-names>YJ</given-names>
            </name>
            <name>
              <surname>Stewart</surname>
              <given-names>CF</given-names>
            </name>
            <name>
              <surname>Gilbertson</surname>
              <given-names>RJ</given-names>
            </name>
          </person-group>
          <article-title>Medulloblastoma Genotype Dictates Blood Brain Barrier Phenotype</article-title>
          <source>Cancer Cell.</source>
          <year>2016</year>
          <volume>29</volume>
          <fpage>508</fpage>
          <lpage>22</lpage>
          <pub-id pub-id-type="doi">10.1016/j.ccell.2016.03.002</pub-id>
          <pub-id pub-id-type="pmid">27050100</pub-id>
        </element-citation>
      </ref>
      <ref id="CR9">
        <label>9.</label>
        <mixed-citation publication-type="other">Perreault S, Chao K, Ramaswamy V, Shih D, Remke M, Luu B, Schubert S, Fisher P, Partap S, Vogel H, Taylor M, Goumnerova L, Cho YJ. Medulloblastoma in the operative theater: are they playing according to their subtypes? Abstracts of papers, WFNO-SNO 2013. Neuro Oncol. 2013;15(3):iii165&#x2013;iii172.</mixed-citation>
      </ref>
      <ref id="CR10">
        <label>10.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Taylor</surname>
              <given-names>MD</given-names>
            </name>
            <name>
              <surname>Northcott</surname>
              <given-names>PA</given-names>
            </name>
            <name>
              <surname>Korshunov</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Remke</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Cho</surname>
              <given-names>YJ</given-names>
            </name>
            <name>
              <surname>Clifford</surname>
              <given-names>SC</given-names>
            </name>
            <name>
              <surname>Eberhart</surname>
              <given-names>CG</given-names>
            </name>
            <name>
              <surname>Parsons</surname>
              <given-names>DW</given-names>
            </name>
            <name>
              <surname>Rutkowski</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Gajjar</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Ellison</surname>
              <given-names>DW</given-names>
            </name>
            <name>
              <surname>Lichter</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Gilbertson</surname>
              <given-names>RJ</given-names>
            </name>
            <name>
              <surname>Pomeroy</surname>
              <given-names>SL</given-names>
            </name>
            <name>
              <surname>Kool</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Pfister</surname>
              <given-names>SM</given-names>
            </name>
          </person-group>
          <article-title>Molecular subgroups of medulloblastoma: the current consensus</article-title>
          <source>Acta Neuropathol</source>
          <year>2012</year>
          <volume>123</volume>
          <fpage>465</fpage>
          <lpage>72</lpage>
          <pub-id pub-id-type="doi">10.1007/s00401-011-0922-z</pub-id>
          <pub-id pub-id-type="pmid">22134537</pub-id>
        </element-citation>
      </ref>
      <ref id="CR11">
        <label>11.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Clifford</surname>
              <given-names>SC</given-names>
            </name>
            <name>
              <surname>Lusher</surname>
              <given-names>ME</given-names>
            </name>
            <name>
              <surname>Lindsey</surname>
              <given-names>JC</given-names>
            </name>
            <name>
              <surname>Langdon</surname>
              <given-names>JA</given-names>
            </name>
            <name>
              <surname>Gilbertson</surname>
              <given-names>RJ</given-names>
            </name>
            <name>
              <surname>Straughton</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Ellison</surname>
              <given-names>DW</given-names>
            </name>
          </person-group>
          <article-title>Wnt/Wingless pathway activation and chromosome 6 loss characterize a distinct molecular sub-group of medulloblastomas associated with a favorable prognosis</article-title>
          <source>Cell Cycle.</source>
          <year>2006</year>
          <volume>5</volume>
          <fpage>2666</fpage>
          <lpage>70</lpage>
          <pub-id pub-id-type="doi">10.4161/cc.5.22.3446</pub-id>
          <pub-id pub-id-type="pmid">17172831</pub-id>
        </element-citation>
      </ref>
      <ref id="CR12">
        <label>12.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ar&#xE9;valo</surname>
              <given-names>JC</given-names>
            </name>
            <name>
              <surname>Chao</surname>
              <given-names>MV</given-names>
            </name>
          </person-group>
          <article-title>Axonal growth: where neurotrophins meet Wnts</article-title>
          <source>Curr Opin Cell Biol</source>
          <year>2005</year>
          <volume>17</volume>
          <fpage>112</fpage>
          <lpage>5</lpage>
          <pub-id pub-id-type="doi">10.1016/j.ceb.2005.01.004</pub-id>
          <pub-id pub-id-type="pmid">15780585</pub-id>
        </element-citation>
      </ref>
      <ref id="CR13">
        <label>13.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Liebner</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Corada</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Bangsow</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Babbage</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Taddei</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Czupalla</surname>
              <given-names>CJ</given-names>
            </name>
            <name>
              <surname>Reis</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Felici</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Wolburg</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Fruttiger</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Taketo</surname>
              <given-names>MM</given-names>
            </name>
            <name>
              <surname>von Melchner</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Plate</surname>
              <given-names>KH</given-names>
            </name>
            <name>
              <surname>Gerhardt</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Dejana</surname>
              <given-names>E</given-names>
            </name>
          </person-group>
          <article-title>Wnt/beta-catenin signaling controls development of the blood&#x2013;brain barrier</article-title>
          <source>J Cell Biol.</source>
          <year>2008</year>
          <volume>183</volume>
          <fpage>409</fpage>
          <lpage>17</lpage>
          <pub-id pub-id-type="doi">10.1083/jcb.200806024</pub-id>
          <pub-id pub-id-type="pmid">18955553</pub-id>
        </element-citation>
      </ref>
      <ref id="CR14">
        <label>14.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cattelino</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Liebner</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Gallini</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Zanetti</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Balconi</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Corsi</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Bianco</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Wolburg</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Moore</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Oreda</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Kemler</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Dejana</surname>
              <given-names>E</given-names>
            </name>
          </person-group>
          <article-title>The conditional inactivation of the beta-catenin gene in endothelial cells causes a defective vascular pattern and increased vascular fragility</article-title>
          <source>J Cell Biol</source>
          <year>2003</year>
          <volume>162</volume>
          <fpage>1111</fpage>
          <lpage>22</lpage>
          <pub-id pub-id-type="doi">10.1083/jcb.200212157</pub-id>
          <pub-id pub-id-type="pmid">12975353</pub-id>
        </element-citation>
      </ref>
      <ref id="CR15">
        <label>15.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Daneman</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Agalliu</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Zhou</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Kuhnert</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Kuo</surname>
              <given-names>CJ</given-names>
            </name>
            <name>
              <surname>Barres</surname>
              <given-names>BA</given-names>
            </name>
          </person-group>
          <article-title>Wnt/beta-catenin signaling is required for CNS, but not non-CNS, angiogenesis</article-title>
          <source>Proc Natl Acad Sci U S A.</source>
          <year>2009</year>
          <volume>106</volume>
          <fpage>641</fpage>
          <lpage>6</lpage>
          <pub-id pub-id-type="doi">10.1073/pnas.0805165106</pub-id>
          <pub-id pub-id-type="pmid">19129494</pub-id>
        </element-citation>
      </ref>
      <ref id="CR16">
        <label>16.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Stenman</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Rajagopal</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Carroll</surname>
              <given-names>TJ</given-names>
            </name>
            <name>
              <surname>Ishibashi</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>McMahon</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>McMahon</surname>
              <given-names>AP</given-names>
            </name>
          </person-group>
          <article-title>Canonical Wnt signaling regulates organ-specific assembly and differentiation of CNS vasculature</article-title>
          <source>Science.</source>
          <year>2008</year>
          <volume>322</volume>
          <fpage>1247</fpage>
          <lpage>50</lpage>
          <pub-id pub-id-type="doi">10.1126/science.1164594</pub-id>
          <pub-id pub-id-type="pmid">19023080</pub-id>
        </element-citation>
      </ref>
      <ref id="CR17">
        <label>17.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Posokhova</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Shukla</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Seaman</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Volate</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Hilton</surname>
              <given-names>MB</given-names>
            </name>
            <name>
              <surname>Wu</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Morris</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Swing</surname>
              <given-names>DA</given-names>
            </name>
            <name>
              <surname>Zhou</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Zudaire</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Rubin</surname>
              <given-names>JS</given-names>
            </name>
            <name>
              <surname>St Croix</surname>
              <given-names>B</given-names>
            </name>
          </person-group>
          <article-title>GPR124 functions as a WNT7-specific coactivator of canonical &#x3B2;-catenin signaling</article-title>
          <source>Cell Rep</source>
          <year>2015</year>
          <volume>10</volume>
          <fpage>123</fpage>
          <lpage>30</lpage>
          <pub-id pub-id-type="doi">10.1016/j.celrep.2014.12.020</pub-id>
          <pub-id pub-id-type="pmid">25558062</pub-id>
        </element-citation>
      </ref>
      <ref id="CR18">
        <label>18.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cullen</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Elzarrad</surname>
              <given-names>MK</given-names>
            </name>
            <name>
              <surname>Seaman</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Zudaire</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Stevens</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Yang</surname>
              <given-names>MY</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>X</given-names>
            </name>
            <name>
              <surname>Chaudhary</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Xu</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Hilton</surname>
              <given-names>MB</given-names>
            </name>
            <name>
              <surname>Logsdon</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Hsiao</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Stein</surname>
              <given-names>EV</given-names>
            </name>
            <name>
              <surname>Cuttitta</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Haines</surname>
              <given-names>DC</given-names>
            </name>
            <name>
              <surname>Nagashima</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Tessarollo</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>St Croix</surname>
              <given-names>B</given-names>
            </name>
          </person-group>
          <article-title>GPR124, an orphan G protein-coupled receptor, is required for CNS-specific vascularization and establishmentof the blood&#x2013;brain barrier</article-title>
          <source>Proc Natl Acad Sci U S A</source>
          <year>2011</year>
          <volume>108</volume>
          <issue>14</issue>
          <fpage>5759</fpage>
          <lpage>64</lpage>
          <pub-id pub-id-type="doi">10.1073/pnas.1017192108</pub-id>
          <pub-id pub-id-type="pmid">21421844</pub-id>
        </element-citation>
      </ref>
      <ref id="CR19">
        <label>19.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Vanhollebeke</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Stone</surname>
              <given-names>OA</given-names>
            </name>
            <name>
              <surname>Bostaille</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Cho</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Zhou</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Maquet</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Gauquier</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Cabochette</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Fukuhara</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Mochizuki</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Nathans</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Stainier</surname>
              <given-names>DY</given-names>
            </name>
          </person-group>
          <article-title>Tip cell-specific requirement for an atypical Gpr124- and Reck-dependent Wnt/&#x3B2;-catenin pathway during brain angiogenesis</article-title>
          <source>Elife</source>
          <year>2015</year>
          <volume>8</volume>
          <fpage>4</fpage>
        </element-citation>
      </ref>
      <ref id="CR20">
        <label>20.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Guo</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Breslin</surname>
              <given-names>JW</given-names>
            </name>
            <name>
              <surname>Wu</surname>
              <given-names>MH</given-names>
            </name>
            <name>
              <surname>Gottardi</surname>
              <given-names>CJ</given-names>
            </name>
            <name>
              <surname>Yuan</surname>
              <given-names>SY</given-names>
            </name>
          </person-group>
          <article-title>VE-cadherin and beta-catenin binding dynamics during histamine-induced endothelial hyperpermeability</article-title>
          <source>Am J Physiol Cell Physiol.</source>
          <year>2008</year>
          <volume>294</volume>
          <fpage>C977</fpage>
          <lpage>84</lpage>
          <pub-id pub-id-type="doi">10.1152/ajpcell.90607.2007</pub-id>
          <pub-id pub-id-type="pmid">18287330</pub-id>
        </element-citation>
      </ref>
      <ref id="CR21">
        <label>21.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yeom</surname>
              <given-names>KW</given-names>
            </name>
            <name>
              <surname>Mobley</surname>
              <given-names>BC</given-names>
            </name>
            <name>
              <surname>Lober</surname>
              <given-names>RM</given-names>
            </name>
            <name>
              <surname>Andre</surname>
              <given-names>JB</given-names>
            </name>
            <name>
              <surname>Partap</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Vogel</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Barnes</surname>
              <given-names>PD</given-names>
            </name>
          </person-group>
          <article-title>Distinctive MRI features of pediatric medulloblastoma subtypes</article-title>
          <source>AJR Am J Roentgenol</source>
          <year>2013</year>
          <volume>200</volume>
          <fpage>895</fpage>
          <lpage>903</lpage>
          <pub-id pub-id-type="doi">10.2214/AJR.12.9249</pub-id>
          <pub-id pub-id-type="pmid">23521467</pub-id>
        </element-citation>
      </ref>
      <ref id="CR22">
        <label>22.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tachibana</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Oki</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Hayashi</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Nonomura</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Yamashima</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Yamashita</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Repetitive intratumoral hemorrhage in medulloblastoma. A case report</article-title>
          <source>Surg Neurol</source>
          <year>1990</year>
          <volume>33</volume>
          <fpage>378</fpage>
          <lpage>83</lpage>
          <pub-id pub-id-type="doi">10.1016/0090-3019(90)90148-I</pub-id>
          <pub-id pub-id-type="pmid">2349533</pub-id>
        </element-citation>
      </ref>
      <ref id="CR23">
        <label>23.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Park</surname>
              <given-names>TS</given-names>
            </name>
            <name>
              <surname>Hoffman</surname>
              <given-names>HJ</given-names>
            </name>
            <name>
              <surname>Hendrick</surname>
              <given-names>EB</given-names>
            </name>
            <name>
              <surname>Humphreys</surname>
              <given-names>RP</given-names>
            </name>
            <name>
              <surname>Becker</surname>
              <given-names>LE</given-names>
            </name>
          </person-group>
          <article-title>Medulloblastoma: clinical presentation and management. Experience at the hospital for sick children, toronto, 1950&#x2013;1980</article-title>
          <source>J Neurosurg</source>
          <year>1983</year>
          <volume>58</volume>
          <fpage>543</fpage>
          <lpage>52</lpage>
          <pub-id pub-id-type="doi">10.3171/jns.1983.58.4.0543</pub-id>
          <pub-id pub-id-type="pmid">6827349</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
